Virtual 2020

Browse: Pre-Congress Content Sunday, 06.09.2020 Monday, 07.09.2020 Tuesday, 08.09.2020 Wednesday, 09.09.2020		View the presentations you missed during Congress! More than 1,100 webcasts and slide presentations, 3,500 e-posters and 4,000 abstracts from the Virtual Congress 2020 and are now available.

Citations should be made in the following way: Authors. Title. Eur Respir J 2020; 55: Suppl. 65, abstract number.

Airway diseases

State of the art session
Chairs: M. Humbert (Le Kremlin-Bicêtre, France), T. Geiser (Bern, Switzerland)
Aims: To evaluate the use of short-acting beta-2 agonist (SABA) monotherapy and oral corticosteroid (OCS) use in asthma; to describe concerns related to the use of inhaled corticosteroids (ICS) in COPD; and to determine the optimal inhalation device for patients with COPD.

Download all media

Is there a problem with short-acting beta-2 agonist monotherapy in asthma? D. Price (Singapore, Singapore)
Is there a problem with oral corticosteroid use in asthma? G. Brusselle (Ghent, Belgium)
Is there a problem with inhaled corticosteroid use in COPD? J. Chalmers (Dundee (Angus), United Kingdom)
ERS Short Guideline: Inhaled corticosteroid withdrawal in COPD M. Miravitlles (Barcelona (CT), Spain)